forecast glp-1 prescriptions growth 2025 drugs are rewriting America's food preferences, says IFF GLP-1 Analogues Market Size to

Clinical studies on GLP-1 receptor agonists show that patients may experience significant weight reduction over time, especially when treatment is combined with healthy nutrition and regular physical activity

Prescribing decisions should be individualised, considering the patient's specific needs, comorbidities, and treatment goals

In that context, the researchers examined the insurance claims of nearly 3,600 pregnancies among women taking GLP-1s, some of whom continued to do so during the first trimester of pregnancy and some of whom stopped

Each discovery reflects the same underlying truth: metabolic health is the foundation on which the rest of the body is built

Nevertheless, it was demonstrated that inadequate weight loss after BS is often associated with increased appetite and an unfavorable postoperative gut hormone profile, including reduced circulating GLP-1 levels [25, 26]